Demonstration of anti-disease immunity to Plasmodium vivax malaria in Sri Lanka using a quantitative method to assess clinical disease

American Journal of Tropical Medicine and Hygiene

Volumn 58, Issue 2, 1998, Pages 204-210

  Karunaweera, Nadira D ^a   Carter, Richard ^b   Grau, Georges E ^c   Mendis, Kamini N ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; DISEASE SEVERITY; ENDEMIC DISEASE; ERYTHROCYTE SEDIMENTATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MALARIA; PLASMODIUM VIVAX; RETICULOCYTE COUNT;

EID: 0031907023     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.58.204     Document Type: Article

References (15)

1. Hill RB, Combornac FJC, Simoes MP, 1943. Observations on the course of malaria in children in an endemic region. Am J Trop Med Hyg 23: 147-162.
2. Trape JF, Rogier C, Konate L, Diagne N, Bouganali H, Canque B, Legros F, Badji A, Ndiaye G, Ndiaye P, Brahimi K, Faye O, Druilhe P, Da Silva LP, 1994. The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg 51: 123-137.
3. Mendis C, Gamage-Mendis AC, De Zoysa APK, Abhayawardena TA, Carter R, Herath PRJ, Mendis KM, 1990. Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immuno-epidemiological studies. Am J Trop Med Hyg 42: 298-308.
4. Bruce-Chwatt LJ, 1986. Clinical course of malaria. Essential Malariology. London: Heinemann Medical Books, 51-72.
5. Bradley D, Newbold CI, Warrell DA, 1996. Malaria. Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine. Oxford: Oxford University Press, 835-863.
6. Bomford R, Mason S, Swash M, 1975. Elementary haematology. Hutchison's Clinical Methods. London: Bailliere Tindall, 133-160.
7. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH, 1989. TNF and disease severity in children with falciparum malaria. N Engl J Med 320: 1586-1591.
8. Kwiatkowski D, Hill AVS, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM, 1990. TNF concentration in fatal cerebral, non-fatal cerebral and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201-1204.
9. Karunaweera ND, Carter R, Grau GE, Kwiatkowski D, Del Giudice G, Mendis KM, 1992. Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients. Clin Exp Immunol 88: 499-505.
10. Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN, 1992. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. P roc Natl Acad Sci USA 89: 3200-3203.
11. Kern P, Hemmer CJ, Damme JV, Gruss HJ, Dietrich M, 1989. Elevated TNF-α and IL-6 serum Levels as markers for complicated P. falciparum malaria. Am J Med 87: 139-143.
12. Fraker DL, Stovroff MC, Merino MJ, Norton JA, 1988. Tolerance to TNF in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med 168: 95-105.
13. Clark IA, Chaudhri G, 1989. Relationships between inflammation and immunopathology of malaria. Malaria: Host Re-spouses to Infection. Stevenson MM, ed. Boca Raton. FL: CRC Press, 128-146.
14. Spriggs DR, Sherman ML, Frei E, Kufe DW, 1987. Tumour necrosis factor. Clinical trials and future directions. TNF and Related Cytokines. Bock G, Marsh J, eds. New York: John Wiley & Sons, 206-219.
15. Perera KM, Carter R, Goonewardene R, Mendis KN, 1994. Transient increase in circulating γ/δ T cells during Plasmodium vivax malarial paroxysms. J Exp Med 179: 311-315.